These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19156464)

  • 21. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.
    Chase JL
    Pharmacotherapy; 2008 Nov; 28(11 Pt 2):23S-30S. PubMed ID: 18980549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T; Lindley C
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
    Brostjan C; Gebhardt K; Gruenberger B; Steinrueck V; Zommer H; Freudenthaler H; Roka S; Gruenberger T
    Clin Cancer Res; 2008 Apr; 14(7):2065-74. PubMed ID: 18381946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The safety of perioperative bevacizumab use].
    Mariani P
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S12-7. PubMed ID: 20172200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of bevacizumab for advanced colorectal cancer].
    Naito M; Hoshino S; Noda N; Nakano M; Matsuo K; Yamauchi Y; Shinohara T; Tanaka S; Yamashita Y
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):83-8. PubMed ID: 20087037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months.
    Pucciarelli S; Gagliardi G; Maretto I; Lonardi S; Friso ML; Urso E; Toppan P; Nitti D
    Ann Surg Oncol; 2009 Apr; 16(4):893-9. PubMed ID: 19189187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial nephritis secondary to bevacizumab treatment in metastatic leiomyosarcoma.
    Barakat RK; Singh N; Lal R; Verani RR; Finkel KW; Foringer JR
    Ann Pharmacother; 2007 Apr; 41(4):707-10. PubMed ID: 17374619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies.
    Zondor SD; Medina PJ
    Ann Pharmacother; 2004; 38(7-8):1258-64. PubMed ID: 15187215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.
    Roddy JV; Partridge SM; Rockey ML; Pruemer JM; Guo JJ; Desai SJ; Safa MM
    Am J Clin Oncol; 2010 Feb; 33(1):36-42. PubMed ID: 19652579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonic anastomotic healing after preoperative chemo-radiotherapy in rat.
    Kuzu MA; Köksoy C; Akyol FH; Uzal D; Kale IT
    Radiat Med; 1999; 17(2):181-7. PubMed ID: 10399789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
    D'Angelica M; Kornprat P; Gonen M; Chung KY; Jarnagin WR; DeMatteo RP; Fong Y; Kemeny N; Blumgart LH; Saltz LB
    Ann Surg Oncol; 2007 Feb; 14(2):759-65. PubMed ID: 17103075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.
    Kabbinavar FF; Flynn PJ; Kozloff M; Ashby MA; Sing A; Barr CE; Grothey A
    Eur J Cancer; 2012 May; 48(8):1126-32. PubMed ID: 22424880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].
    Hirano A; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Imai K; Nakagawa R; Adachi K; Shiragami R; Yasuda H
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1087-91. PubMed ID: 22790044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of hypertension in advanced, recurrent colorectal cancer patients treated with first-line bevacizumab].
    Yamamura K; Ishigure K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):85-8. PubMed ID: 21368463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases.
    van der Pool AE; Marsman HA; Verheij J; Ten Kate FJ; Eggermont AM; Ijzermans JN; Verhoef C
    J Surg Oncol; 2012 Dec; 106(7):892-7. PubMed ID: 22552819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases.
    Bhaskara A; Eng C
    Clin Colorectal Cancer; 2008 Jan; 7(1):65-8. PubMed ID: 18279580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer.
    Saif MW; Longo WL; Israel G
    Clin Colorectal Cancer; 2008 Mar; 7(2):144-8. PubMed ID: 18501075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Idiopathic thrombocytopenic purpura during chemotherapy for liver metastasis of rectal cancer].
    Murata K; Mikami K; Yamada M; Ide Y; Owada Y; Nishigaki T; Nagase H; Mukai R; Momozane T; Murakami M; Okada K; Yanagisawa T; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2605-7. PubMed ID: 21224653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer.
    Martel G; Al-Suhaibani Y; Moloo H; Haggar F; Friedlich M; Mamazza J; Poulin EC; Stern H; Boushey RP
    Dis Colon Rectum; 2008 Aug; 51(8):1195-201. PubMed ID: 18523823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.